Efficacy, safety, and tolerability of doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: results through week 96 from IMPAACT 2014.

Supattra RungmaitreeLinda AurpibulBrookie M BestXiang LiMeredith G WarshawHong WanNicole H TobinPatricia JumesRandi LeavittKatie McCarthyRachel ScheckterPradthana OunchanumAvy ViolariHedy TepplerHavilland CampbellChelsea KrotjeEllen TownleyJack MoyeAnn J Melvinnull null

Published in: Journal of the Pediatric Infectious Diseases Society (2023)

We found once daily dosing of DOR FDC to be safe and well tolerated for maintaining viral suppression through 96 weeks in adolescents living with HIV-1.

Keyphrases

young adults
physical activity
sars cov
open label
randomized controlled trial
antiretroviral therapy
double blind